Smart Investor brings a research report on Weekly basis - For the week ending 20th December, 2015 we have made a recommendation.

1. WEEKLY PICK
20 DEC 2015
BROUGHT TO YOU BY
SMART INVESTOR
BANGALORE

2. DISCLAIMER
• The information and views in this report, our website & all the service we provide are
believed to be reliable, but we do not accept any responsibility (or liability) for errors of
fact or opinion. Users have the right to choose the product/s that suits them the most.
• Sincere efforts have been made to present the right investment perspective. The
information contained herein is based on technical analysis and up on sources that we
consider reliable.
• This material is for personal information and based upon it & takes no responsibility
• The information given herein should be treated as only factor, while making investment
decision. The report does not provide individually tailor-made investment advice. We
recommend that investors independently evaluate particular investments and strategies,
and encourages investors to seek the advice of a financial adviser. We aer not responsible
for any transaction conducted based on the information given in this report, which is in
violation of rules and regulations of NSE and BSE.
• The share price projections shown are not necessarily indicative of future price
performance. The information herein, together with all estimates and forecasts, can
change without notice. It is understood that anyone who is browsing through the site has
done so at his free will and does not read any views expressed as a recommendation for
which either the site or its owners or anyone can be held responsible for . Any surfing and
reading of the information is the acceptance of this disclaimer.
• All Rights Reserved.

3. ABOUT THE COMPANY
12/23/15
Kiran Mazumdar Shaw is an Indian
entrepreneur. She is the chairman and
managing director of Biocon Limited, a
biotechnology company based in Bangalore,
India and the current chairperson of IIM-
Bangalore

4. BACK GROUND
• Syngene International Limited is an India-based contract research and
manufacturing company.
• The Company offers a suite of integrated, end-to-end discovery and
development services for molecular entities (NMEs) across industrial
sectors, including pharmaceutical, biotechnology, agrochemicals,
consumer health, animal health, cosmetic and nutrition companies
• Bristol Myers Squibb, Abbott Laboratories (Singapore) Pte. Ltd and Baxter
International Inc. are three of its major clients. It also has smaller clients
such as Achillion Pharmaceuticals Inc., Aquinox Pharmaceuticals Inc. and
Saniona AB.

5. HIGHLIGHTS
• Clinigene is the clinical trials subsidiary of Syngene, which
accounts for less than 10% of its revenue.
• Syngene has so far developed monoclonal antibodies,
glycoproteins, complex proteins, conjugated proteins in E. coli
and Chinese hamster ovary cells.
• The contract research provider has 2,685 employees, of whom
2,122 are scientists, with an average age of less than 28 years.
24% of revenue, or Rs.200 crore, went toward employee
benefits in the year ended March.

6. HIGHLIGHTS
• Seventy percent of its revenue comes from the top 10 clients.
Bristol Myers Squibb alone contributes 30%. These clients
have long-term contracts.
• It has 400 scientists working exclusively for Bristol Myers
Squibb. It also has 150 scientists for Baxter and 30 scientists
for Abbott..
• Syngene has 900,000 sq. ft of work space in Bengaluru and is
also in the process of setting up a 200,000 sq. ft research
centre and a manufacturing facility.There is a reservation for
retail participation to encourage the small investors to take
part in IPOs

7. RECOMMENDATION
• Expected target price
• 3 months – Rs.426
• 12 months – Rs.527
• Returns
• 1 week High 390 – Low 348
• 1 month High 393 – Low 360
• 3 months High 396 – Low 316

8. GET IN TOUCH TODAY !
Learn2Gain
No.24 Pattamal Plaza
3rd Cross, Kammanahalli
BANGALORE 560084
8105-737-966
intellinvestor@gmail.com
www.ingeniousinvestor.blogspot.in
www.twitter.com/SmartInvestor
https://www.facebook.com/SmartInvestor1